Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.34 USD | +22.51% | +31.75% | -23.62% |
Apr. 22 | Xylo Technologies Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 18 | Medigus Ltd. will Change its Ticker to XYLO from MDGS | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 9.871 | 7.186 | 30.22 | 23.78 | 7.656 | 5.656 |
Enterprise Value (EV) 1 | -0.7539 | 0.3021 | 7.964 | -1.946 | -7.259 | 2.906 |
P/E ratio | -0.81 x | -0.48 x | -2.95 x | 5 x | -0.77 x | -0.34 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 22.6 x | 26.3 x | 56.9 x | 2.35 x | 0.08 x | 0.06 x |
EV / Revenue | -1.73 x | 1.11 x | 15 x | -0.19 x | -0.08 x | 0.03 x |
EV / EBITDA | 0.11 x | -0.07 x | -1.08 x | 0.25 x | 1.35 x | -0.42 x |
EV / FCF | 0.21 x | -0.11 x | -2.17 x | 0.24 x | 12.6 x | -0.41 x |
FCF Yield | 482% | -928% | -46% | 420% | 7.95% | -244% |
Price to Book | 1.22 x | 1.07 x | 1.32 x | 0.48 x | 0.2 x | 0.26 x |
Nbr of stocks (in thousands) | 253 | 275 | 1,055 | 1,585 | 1,639 | 1,735 |
Reference price 2 | 39.00 | 26.10 | 28.65 | 15.00 | 4.670 | 3.260 |
Announcement Date | 3/28/19 | 4/21/20 | 5/14/21 | 4/29/22 | 5/3/23 | 4/22/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 0.436 | 0.273 | 0.531 | 10.12 | 91.86 | 91.72 |
EBITDA 1 | -6.638 | -4.175 | -7.349 | -7.892 | -5.385 | -6.837 |
EBIT 1 | -6.672 | -4.198 | -7.465 | -8.196 | -8.581 | -10.82 |
Operating Margin | -1,530.28% | -1,537.73% | -1,405.84% | -81% | -9.34% | -11.79% |
Earnings before Tax (EBT) 1 | -6.578 | -14.18 | -6.841 | 4.151 | -10.1 | -21.81 |
Net income 1 | -6.598 | -14.18 | -4.325 | 6.794 | -9.815 | -16.02 |
Net margin | -1,513.3% | -5,193.41% | -814.5% | 67.15% | -10.68% | -17.47% |
EPS 2 | -48.00 | -54.44 | -9.723 | 3.000 | -6.038 | -9.504 |
Free Cash Flow 1 | -3.632 | -2.803 | -3.666 | -8.175 | -0.5772 | -7.094 |
FCF margin | -832.97% | -1,026.65% | -690.32% | -80.8% | -0.63% | -7.73% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/28/19 | 4/21/20 | 5/14/21 | 4/29/22 | 5/3/23 | 4/22/24 |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2022 S1 |
---|---|
Net sales | - |
EBITDA | - |
EBIT | - |
Operating Margin | - |
Earnings before Tax (EBT) | - |
Net income 1 | -3.59 |
Net margin | - |
EPS 2 | -2.250 |
Dividend per Share | - |
Announcement Date | 9/23/22 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 10.6 | 6.88 | 22.3 | 25.7 | 14.9 | 2.75 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -3.63 | -2.8 | -3.67 | -8.18 | -0.58 | -7.09 |
ROE (net income / shareholders' equity) | -97.1% | -175% | -39.9% | 10.4% | -19.2% | -49.9% |
ROA (Net income/ Total Assets) | -45.2% | -21.4% | -20.4% | -11.1% | -6.82% | -8.37% |
Assets 1 | 14.6 | 66.39 | 21.17 | -61.05 | 144 | 191.5 |
Book Value Per Share 2 | 31.90 | 24.40 | 21.80 | 30.90 | 23.80 | 12.60 |
Cash Flow per Share 2 | 42.00 | 25.60 | 21.20 | 15.10 | 12.20 | 5.010 |
Capex 1 | 0 | 0.06 | 0.32 | 0.14 | 0.07 | 0.05 |
Capex / Sales | 0.92% | 22.71% | 61.02% | 1.39% | 0.08% | 0.06% |
Announcement Date | 3/28/19 | 4/21/20 | 5/14/21 | 4/29/22 | 5/3/23 | 4/22/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.62% | 3.62M | |
+11.09% | 227B | |
+14.95% | 198B | |
+18.96% | 142B | |
+31.26% | 111B | |
+1.03% | 64.16B | |
+18.60% | 54.1B | |
+5.82% | 51.41B | |
+10.31% | 45.32B | |
+5.38% | 37.32B |
- Stock Market
- Equities
- XYLO Stock
- Financials Xylo Technologies Ltd